Age Differences in Cardiopulmonary Exercise Testing Parameters in Heart Failure with Reduced Ejection Fraction

被引:1
|
作者
Garcia Bras, Pedro [1 ]
Goncalves, Antonio Valentim [1 ]
Reis, Joao Ferreira [1 ]
Moreira, Rita Ilhao [1 ]
Pereira-da-Silva, Tiago [1 ]
Rio, Pedro [1 ]
Timoteo, Ana Teresa [1 ,2 ]
Silva, Sofia [1 ]
Soares, Rui M. [1 ]
Ferreira, Rui Cruz [1 ]
机构
[1] Cent Lisbon Hosp Univ Ctr, St Marta Hosp, Cardiol Dept, P-1169024 Lisbon, Portugal
[2] NOVA Med Sch, Fac Ciencias Med, NMS FCM, P-1169056 Lisbon, Portugal
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 09期
关键词
heart failure with reduced ejection fraction; cardiopulmonary exercise testing; peak oxygen consumption; VE/VCO2; slope; age; heart transplantation; ELDERLY-PATIENTS; VENTILATORY EFFICIENCY; PROGNOSTIC VALUE; VE/VCO2; SLOPE; CARDIAC TRANSPLANTATION; KIDNEY INDEXES; POSITION PAPER; PEAK VO2; MODEL; STRATIFICATION;
D O I
10.3390/medicina59091685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Cardiopulmonary exercise testing (CPET) is a cornerstone of risk stratification in heart failure with reduced ejection fraction (HFrEF). However, there is a paucity of evidence on its predictive power in older patients. The aim of this study was to evaluate the prognostic power of current heart transplantation (HTx) listing criteria in HFrEF stratified according to age groups. Materials and Methods: Consecutive patients with HFrEF undergoing CPET between 2009 and 2018 were followed-up for cardiac death and urgent HTx. Results: CPET was performed in 458 patients with HFrEF. The composite endpoint occurred in 16.8% of patients <= 50 years vs. 14.1% of patients >= 50 years in a 36-month follow-up. Peak VO2 (pVO(2)), VE/VCO2 slope and percentage of predicted pVO(2) were strong independent predictors of outcomes. The International Society for Heart and Lung Transplantation thresholds of pVO(2) <= 12 mL/kg/min (<= 14 if intolerant to fi-blockers), VE/VCO2 slope > 35 and percentage of predicted pVO(2) <= 50% presented a higher overall diagnostic effectiveness in younger patients (less than or similar to 50 years). Specific thresholds for each age subgroup outperformed the traditional cut-offs. Conclusions: Personalized age-specific thresholds may contribute to an accurate risk stratification in HFrEF. Further studies are needed to address the gap in evidence between younger and older patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Cardiopulmonary exercise testing as a prognosis-assessing tool in heart failure with preserved ejection fraction
    da Conceicao, C. Rozados
    Krannich, A.
    Zach, V.
    Pinto, R.
    Deichl, A.
    Feuerstein, A.
    Schleussner, L.
    Edelmann, F.
    ESC HEART FAILURE, 2025,
  • [22] Combination of cardiopulmonary exercise testing and echocardiography to validate the diagnosis of heart failure with preserved ejection fraction
    Nitschke, T.
    Abazi, F.
    Tulka, S.
    Knippschild, S.
    Heuer, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 110 - 110
  • [23] Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
    Veenis, Jesse F.
    Brunner-La Rocca, Hans-Peter
    Linssen, Gerard C. M.
    Geerlings, Peter R.
    Van Gent, Marco W. F.
    Aksoy, Ismail
    Oosterom, Liane
    Moons, Arno H. M.
    Hoes, Arno W.
    Brugts, Jasper J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (13) : 1399 - 1407
  • [24] Exercise limitations in heart failure with reduced and preserved ejection fraction
    Poole, David C.
    Richardson, Russell S.
    Haykowsky, Mark J.
    Hirai, Daniel M.
    Musch, Timothy I.
    JOURNAL OF APPLIED PHYSIOLOGY, 2018, 124 (01) : 208 - 224
  • [25] Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
    Nottebohm, Pia, I
    Dumitrescu, Daniel
    Hamacher, Stefanie
    Hohmann, Christopher
    Madershahian, Navid
    Baldus, Stephan
    Reuter, Hannes
    Halbach, Marcel
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2022, 16
  • [26] Cardiopulmonary exercise test and sudden cardiac death risk in heart failure with reduced ejection fraction patients
    Joao Pedro Dias Ferreira Reis, J. P.
    Goncalves, A.
    Bras, P.
    Ilhao Moreira, R.
    Pereira Silva, T.
    Timoteo, A.
    Soares, R.
    Cruz Ferreira, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 75 - 75
  • [27] Baroreflex activation therapy in heart failure with reduced ejection fraction improves cardiopulmonary function during exercise
    Nottebohm, P.
    Dumitrescu, D.
    Madershahian, N.
    Baldus, S.
    Reuter, H.
    Halbach, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 482 - 482
  • [28] Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction
    Pandey, Ambarish
    Omar, Wally
    Ayers, Colby
    LaMonte, Michael
    Klein, Liviu
    Allen, Norrina B.
    Kuller, Lewis H.
    Greenland, Philip
    Eaton, Charles B.
    Gottdiener, John S.
    Lloyd-Jones, Donald M.
    Berry, Jarett D.
    CIRCULATION, 2018, 137 (17) : 1814 - +
  • [29] Cardiopulmonary exercise responses in patients with non-ischemic heart failure and a mildly reduced ejection fraction
    Harada, Ken
    Yamada, Sumio
    Mamiya, Kumiko
    Higo, Sayaka
    Suzuki, Hitomi
    Teshima, Yuto
    Matsunaga, Shun
    Harada, Kazuhiro
    Nagao, Tomoyuki
    Shinoda, Norihiro
    Kato, Masataka
    Marui, Nobuyuki
    Amano, Tetsuya
    Murohara, Toyoaki
    FUTURE CARDIOLOGY, 2022, 18 (08) : 627 - 634
  • [30] Gender differences in the treatment of heart failure with reduced ejection fraction
    Eric Monteiro, E.
    Pedro Barbosa, J.
    Guimaraes, J.
    Fernandes, D.
    Costa, G.
    Gomes, A. R. M.
    Saleiro, C.
    Campos, D.
    Sousa, J.
    Lopes, J.
    Puga, L.
    Teixeira, R.
    Lourenco, C.
    Madeira, M.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 52 - 52